Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

REQUIP™ MODUTAB prolonged-release tablets 2mg, 28pcs

🔥 6 items sold in last 3 hours
21 people are viewing this product
Active Ingredient:

Manufacturer:

$118.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

REQUIP™ MODUTAB prolonged-release tablets 4mg, 28pcs

$178.00
Add to cart

REQUIP™ MODUTAB prolonged-release tablets 8mg, 28pcs

$315.00
Add to cart

Analogs of REQUIP™ MODUTAB

L-THYROXINE BERLIN-CHEMIE™ tablets 125mcg, 100pcs

$12.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 150mcg, 100pcs

$13.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 50mcg, 50pcs

$7.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 75mcg, 100pcs

$10.00
Add to cart

Table of Contents

REQUIP™ MODUTAB 2mg Tablets Buy Online

Requip Modutab: A Comprehensive Overview

Managing the symptoms of Parkinson’s disease can be challenging, but advancements in medication offer hope for improved quality of life. Requip Modutab, a prolonged-release formulation of ropinirole, is one such advancement, designed to provide consistent symptom relief throughout the day.

This medication is specifically indicated for the treatment of Parkinson’s disease in adults. It’s particularly useful in the early stages of the disease when a dopaminergic therapy is needed. The prolonged-release formulation ensures a steadier release of the active ingredient, potentially minimizing fluctuations in symptom control.

Requip Modutab offers a convenient once-daily dosing schedule, enhancing adherence to the treatment plan. This ease of administration contributes to better patient compliance and improved long-term management of Parkinson’s symptoms.

Understanding Requip Modutab

Requip Modutab is a medication containing ropinirole, a non-ergot dopamine agonist. Unlike immediate-release formulations, Requip Modutab is designed for prolonged release, meaning the active ingredient is released slowly and steadily over time. This controlled release is intended to provide more consistent symptom management compared to medications that release their active ingredient quickly.

The prolonged-release characteristic of Requip Modutab is a key differentiator. This controlled delivery is crucial for managing the fluctuating nature of Parkinson’s disease symptoms. By providing a more consistent level of ropinirole in the body, the medication aims to reduce the occurrence of “on-off” periods, where symptoms dramatically improve and worsen throughout the day.

Requip Modutab comes in tablets, and the dosage is typically adjusted based on individual patient needs and response to therapy. It’s important to follow the prescribed dosage and schedule as directed by a healthcare professional. Never adjust the dosage independently. Always consult your physician for adjustments or concerns.

The mechanism of action involves stimulating dopamine receptors in the brain. Dopamine is a neurotransmitter crucial for motor control. In Parkinson’s disease, dopamine production is reduced, leading to various motor impairments. Requip Modutab aims to alleviate these symptoms by mimicking the effects of dopamine.

Mechanism of Action

Requip Modutab exerts its therapeutic effects by acting as a highly selective non-ergot dopamine agonist. This means it preferentially binds to and activates dopamine receptors in the brain, specifically the D2 and D3 receptors. These receptors play a critical role in motor control and coordination.

In Parkinson’s disease, there’s a significant deficiency in dopamine, a neurotransmitter essential for smooth, controlled movements. By stimulating these dopamine receptors, Requip Modutab helps to alleviate the motor symptoms associated with the disease. This stimulation helps to restore a degree of neurotransmission.

The prolonged-release formulation of Requip Modutab ensures a more consistent and sustained activation of dopamine receptors. This controlled release is designed to minimize the fluctuations in therapeutic effect that can occur with immediate-release formulations, leading to a more stable and predictable response.

Importantly, Requip Modutab’s action is primarily focused on the central nervous system, affecting the brain’s dopamine pathways. While peripheral effects may occur, the primary mechanism focuses on improving motor function by targeting the dopaminergic pathways directly involved in movement control.

Dosage and Administration

Requip Modutab is administered orally, meaning it’s taken by mouth. The tablets should be swallowed whole; they should not be chewed, crushed, or broken. This ensures the controlled release mechanism of the medication functions as intended, providing consistent drug levels throughout the day.

The dosage of Requip Modutab is individualized and determined by a healthcare professional based on factors such as the severity of the patient’s symptoms and their overall health. It’s crucial to follow the prescribed dosage regimen precisely, as adjustments should only be made under medical supervision. Never alter the dosage without consulting your doctor.

Typically, treatment begins with a low dose, which is gradually increased over time as needed. The goal is to find the optimal dose that effectively manages Parkinson’s symptoms while minimizing potential side effects. This titration process is closely monitored by the prescribing physician to ensure safety and efficacy.

It’s generally recommended to take Requip Modutab at the same time each day, regardless of food intake. Maintaining a consistent dosing schedule helps to maintain stable blood levels of ropinirole, which contributes to more consistent symptom control. Consistency is key to achieving optimal therapeutic outcomes.

Potential Benefits of Requip Modutab

Requip Modutab offers several potential benefits for patients with Parkinson’s disease, primarily focusing on improving motor control and reducing the debilitating effects of this progressive neurological condition. The sustained-release formulation plays a crucial role in maximizing these benefits.

One key advantage is the potential for improved motor function. By providing a more consistent level of dopamine stimulation, Requip Modutab may help to reduce the severity of motor fluctuations, such as the “on-off” phenomenon often experienced by Parkinson’s patients. This can translate to smoother, more controlled movements and improved daily functioning.

Another potential benefit is the enhancement of quality of life. Improved motor control can lead to greater independence in daily activities, reduced reliance on caregivers, and increased participation in social and recreational pursuits. This improved quality of life is a significant factor for patients and their families.

The convenience of once-daily dosing is also a significant advantage. This simplifies the medication regimen, potentially improving adherence and reducing the burden of managing multiple daily doses. Better adherence to the prescribed medication regimen leads to better disease management.

Furthermore, Requip Modutab’s potential to reduce the severity of non-motor symptoms, such as sleep disturbances and daytime sleepiness, in some patients should also be noted, although this is not always the primary indication for its use. These benefits can contribute to a significant improvement in overall well-being.

Pros

  • Improved Motor Control: Requip Modutab’s sustained-release mechanism can lead to more consistent symptom management, reducing motor fluctuations and improving the smoothness and control of movements. This can significantly enhance daily functioning and independence.
  • Enhanced Quality of Life: By lessening the impact of Parkinson’s symptoms, Requip Modutab can positively affect a patient’s overall quality of life, allowing for increased participation in social activities and a greater sense of well-being. This is a significant benefit for both the patient and their family.
  • Convenient Once-Daily Dosing: The single daily dose simplifies the medication regimen, making it easier for patients to adhere to their prescribed treatment plan. This improved adherence is crucial for effective long-term management of Parkinson’s disease.
  • Potential for Reduced Non-Motor Symptoms: While not always a primary indication, some patients may experience a reduction in non-motor symptoms such as sleep disturbances and daytime sleepiness. These improvements contribute to a better overall health status.
  • Controlled Release Technology: The prolonged-release formulation ensures a steady supply of medication, minimizing the peaks and troughs in blood levels that can occur with immediate-release medications. This helps maintain a consistent therapeutic effect throughout the day.

Potential Side Effects of Requip Modutab

While Requip Modutab can offer significant benefits, it’s important to be aware of the potential side effects. These side effects vary in severity and frequency among individuals. Some are common, while others are less frequent but may require medical attention.

Nausea and vomiting are among the more commonly reported side effects, often occurring during the initial stages of treatment as the body adjusts to the medication. These gastrointestinal disturbances usually lessen over time as the dosage is gradually increased. Proper hydration and dietary adjustments can sometimes help mitigate these effects.

Dizziness and somnolence (sleepiness) are other potential side effects that can impact daily activities. These effects can be more pronounced at the beginning of treatment and might lessen with continued use. Caution should be exercised when operating machinery or driving until the effects of the medication are fully understood.

More serious, though less frequent, side effects include orthostatic hypotension (a sudden drop in blood pressure upon standing), which can cause dizziness or fainting. Additionally, hallucinations and confusion have been reported in some cases, particularly in older adults. Immediate medical attention is necessary if these symptoms occur.

Other potential side effects can include fatigue, constipation, and swelling in the extremities. It’s vital to report any concerning side effects to your doctor promptly. They can assess the severity and determine if dosage adjustments or alternative treatment options are necessary. Open communication with your physician is essential for safe and effective medication management.

Cons

  • Gastrointestinal Distress: Nausea and vomiting are common side effects, particularly at the start of treatment. These symptoms can be disruptive and may require adjustments to dosage or supportive care.
  • Drowsiness and Dizziness: Somnolence and dizziness can impair daily activities and necessitate caution when driving or operating machinery. These side effects can limit a patient’s ability to perform tasks requiring alertness.
  • Orthostatic Hypotension: A sudden drop in blood pressure upon standing can lead to dizziness or fainting, posing a risk of falls and injury. Patients should be aware of this potential risk and take precautions.
  • Neuropsychiatric Effects: Hallucinations and confusion, while less frequent, are serious potential side effects. These can significantly impact a patient’s mental well-being and require immediate medical attention.
  • Individual Variability: The response to Requip Modutab can vary greatly between patients. What works well for one person may not be as effective or may cause more significant side effects in another. Careful monitoring and adjustments are often necessary.

Important Considerations

Before starting treatment with Requip Modutab, it’s crucial to have an open discussion with your doctor about your medical history, including any pre-existing conditions or medications you are currently taking. This is essential to assess potential drug interactions and ensure the medication is appropriate for your individual circumstances.

Drug interactions can occur with other medications, so it’s vital to provide your doctor with a complete list of all medications, supplements, and herbal remedies you’re using. Some interactions can either reduce the effectiveness of Requip Modutab or increase the risk of side effects. Your doctor will assess these potential interactions and make necessary adjustments.

Patients with a history of liver or kidney disease should be particularly cautious when taking Requip Modutab. These organs play a vital role in processing and eliminating the medication from the body. Impaired liver or kidney function can lead to an accumulation of the drug, increasing the risk of side effects. Dosage adjustments may be necessary in these cases.

Regular monitoring of your health is essential while taking Requip Modutab. Your doctor may schedule regular check-ups to assess the effectiveness of the treatment, monitor for any side effects, and adjust the dosage as needed. This proactive approach helps to ensure the safest and most effective treatment.

Finally, remember that Requip Modutab is not a cure for Parkinson’s disease; it’s a medication designed to manage the symptoms. It’s a crucial part of a comprehensive treatment plan that may also include lifestyle modifications, physical therapy, and other therapeutic interventions. A holistic approach is often the most effective strategy for managing Parkinson’s disease.

Conclusion

Requip Modutab represents a significant advancement in the management of Parkinson’s disease symptoms. Its prolonged-release formulation offers the potential for improved motor control and a better quality of life for many patients by providing more consistent dopamine receptor stimulation. The convenience of once-daily dosing also enhances adherence to the treatment regimen.

However, it’s crucial to acknowledge the potential side effects associated with Requip Modutab. These range from common gastrointestinal issues to more serious neuropsychiatric events. Open communication with your healthcare provider is paramount to carefully weigh the potential benefits against the risks and to manage any side effects effectively.

Individual responses to Requip Modutab vary, highlighting the importance of personalized treatment plans. Regular monitoring by your doctor is essential to ensure the medication is working effectively and safely for you. This ongoing assessment allows for timely adjustments to the dosage or consideration of alternative therapies as needed.

Ultimately, Requip Modutab, when used appropriately under medical supervision, can be a valuable tool in managing the symptoms of Parkinson’s disease. However, it’s vital to remember that this medication is just one component of a comprehensive approach to managing this complex condition. A collaborative effort between patient and physician is key to optimizing treatment outcomes and maximizing quality of life.

Further Information

For comprehensive and up-to-date information regarding Requip Modutab, including detailed prescribing information, potential drug interactions, and a complete list of potential side effects, it is strongly recommended to consult the official prescribing information provided by the manufacturer. This document offers the most accurate and detailed information available.

Furthermore, it’s crucial to remember that the information provided here should not be considered a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare professional before starting any new medication, including Requip Modutab. They can assess your individual needs and determine if this medication is appropriate for you.

Your physician can provide personalized guidance on dosage, potential interactions with other medications you might be taking, and how to best manage any side effects that may occur. Regular follow-up appointments with your doctor are also essential for ongoing monitoring and adjustment of your treatment plan as needed.

Additional resources, such as patient support groups and reputable online health information websites, can provide valuable information and support for individuals living with Parkinson’s disease. These resources can offer practical advice, coping strategies, and a sense of community. Connecting with others who understand your condition can be incredibly helpful.

Finally, remember that the management of Parkinson’s disease is often a collaborative process. Open communication between you, your doctor, and other members of your healthcare team is essential for optimizing your treatment and achieving the best possible health outcomes. Active participation in your care plan is key to success.

  • Requip™ Modutab Prolonged-Release Tablets 2Mg, 28Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Requip™ Modutab Prolonged-Release Tablets 2Mg, 28Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Requip™ Modutab Prolonged-Release Tablets 2Mg, 28Pcs Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “REQUIP™ MODUTAB prolonged-release tablets 2mg, 28pcs”

Your email address will not be published. Required fields are marked

Similar products

TIDOMET™ FORTE tablets 250mg+25mg, 100pcs

$43.00
Add to cart

PRONORAN™ controlled-release tablets 50mg, 30pcs

$27.00
Add to cart

PRAMIPEXOLE™ tablets 0.25mg, 30pcs

$14.00
Add to cart

PRAMIPEXOLE™ tablets 1mg, 30pcs

$58.00
Add to cart

PK-MERZ™ infusion solution 200mg/500ml, 500ml 2pcs

$90.00
Add to cart

PK-MERZ™ tablets 100mg, 30pcs

$15.00
Add to cart

NAKOM™ tablets 250mg+25mg, 100pcs

$89.00
Add to cart

MIRAPEX PD™ prolonged-release tablets 0.375mg, 10pcs

$10.00
Add to cart

MIRAPEX PD™ prolonged-release tablets 1.5mg, 30pcs

$98.00
Add to cart

MIRAPEX PD™ prolonged-release tablets 3mg, 30pcs

$175.00
Add to cart

MIRAPEX™ tablets 0.25mg, 30pcs

$17.00
Add to cart

MIRAPEX™ tablets 1mg, 30pcs

$69.00
Add to cart

MIDANTAN™ tablets 100mg, 100pcs

$15.00
Add to cart

MENDILEX™ tablets 2mg, 50pcs

$9.00
Add to cart

LEVODOPA/CARBIDOPA/ENTACAPONE-TEVA™ tablets 100mg+25mg+200mg, 30pcs

$233.00
Add to cart

LEVODOPA/CARBIDOPA/ENTACAPONE-TEVA™ tablets 150mg+37.5mg+200mg, 30pcs

$217.00
Add to cart

LEVODOPA+BENSERAZIDE capsules 200mg+50mg, 100pcs

$79.00
Add to cart

BROMOCRIPTINE-RICHTER™ tablets 2.5mg, 30pcs

$32.00
Add to cart

BROMOCRIPTINE tablets 2.5mg, 30pcs

$22.00
Add to cart

BENZIEL™ tablets 100mg+25mg, 100pcs

$57.00
Add to cart

AZILECT™ tablets 1mg, 100pcs

$1,294.00
Add to cart

AZILECT™ tablets 1mg, 30pcs

$504.00
Add to cart
Select your currency